Speakers

Mark Lowdell

CSO/CMO • INmune Bio

Prof. Lowdell has been a Chief Scientific Officer and Chief Manufacturing Officer since the formation of the Company in September 2015.   Prof. Lowdell is Professor of Cell and Tissue Therapy at University College London, where he has led a translational immunotherapy group since 1994.  Since February 2009, Prof. Lowdell has also been Director of Cellular Therapy at the Royal Free London NHS Foundation Trust.   He received his PhD in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.

Also speaking

Uta Griesenbach

Professor of Molecular Medicine, National Heart and Lung Institute • Imperial College London

Mark Throsby

Chief Scientific Officer • Gadeta

Amir Hefni

Worldwide Commercial and Region Europe Head for Cell & Gene • Novartis

Event Info

Image

2022 Spotlight Roundtables

Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.
Image

Pub & Pints RSVP

Let us know you’re planning on attending.